Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
By Evelina Tacconelli, E. Carrara, A. Savoldi, S. Harbarth, M. Mendelson, D. Monnet, C. Pulcini, G. Kahlmeter, J. Kluytmans, Yehuda Carmeli and 72 more. Lancet. Infectious Diseases (Print), 2017
4,785 citations recorded by the source corpus.
BACKGROUND The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity and mortality worldwide. Due to its large public health and societal implications, multidrug-resistant tuberculosis has been long regarded by WHO as a global priority for investment in new drugs. In 2016, WHO was requested by member states to create a priority list of other antibiotic-resistant bacteria to support research and development of effective drugs. METHODS We used a multicriteria decision analysis method to prioritise antibiotic-resistant bacteria; this method involved the identification of relevant criteria to assess priority against which each antibiotic-resistant bacterium was rated. The final priority ranking of the antibiotic-resistant bacteria was established after a preference-based survey was used to obtain expert weighting of criteria. FINDINGS We selected 20 bacterial species with 25 patterns of acquired resistance and ten criteria to assess priority: mortality, health-care burden, community burden, prevalence of resistance, 10-year trend of resistance, transmissibility, preventability in the community setting, preventability in the health-care setting, treatability, and pipeline. We stratified the priority list into three tiers (critical, high, and medium priority), using the 33rd percentile of the bacterium's total scores as the cutoff. Critical-priority bacteria included carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa, and carbapenem-resistant and third-generation cephalosporin-resistant Enterobacteriaceae. The highest ranked Gram-positive bacteria (high priority) were vancomycin-resistant Enterococcus faecium and meticillin-resistant Staphylococcus aureus. Of the bacteria typically responsible for community-acquired infections, clarithromycin-resistant Helicobacter pylori, and fluoroquinolone-resistant Campylobacter spp, Neisseria gonorrhoeae, and Salmonella typhi were included in the high-priority tier. INTERPRETATION Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria. The global strategy should include antibiotic-resistant bacteria responsible for community-acquired infections such as Salmonella spp, Campylobacter spp, N gonorrhoeae, and H pylori. FUNDING World Health Organization.
Subfields: Applied Microbiology and Biotechnology, Infectious Diseases, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/3897970f90259a5d4e6a7163a6867cd73943a9f1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Infectious Diseases
In Molecular Medicine
Citations in the corpus
- A new antibiotic selectively kills Gram-negative pathogens (2019, neutral): “The WHO has recently classified these drug resistant pathogens as a critical priority for global human health 5 .”
- CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database (2022, background): “the World Health Organization’s (WHO) priority list of antibiotic resistant bacteria (2,25).”
- Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions (2018, methodology): “Search strategy and selection criteria The systematic review was developed partly as a component of the WHO priority exercise aimed at rating 25 antibiotic-resistant bacteria, including HP, according to ten preselected criteria to provide indications for research and development of new effective ant”
- Chitosan as a Wound Dressing Starting Material: Antimicrobial Properties and Mode of Action (2019, background): “Studies revealed that the absence of d-alanyl esters can increase the negative charge of the cell surface and facilitate the attraction of cationic molecules, thus increasing the sensitivity of the cell to such antimicrobials [111].”
- CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database (2019, background): “In total, CARD Resistomes & Variants includes in silico surveillance of 82 pathogens of public health and AMR relevance, including each pathogen from the World Health Organization’s (WHO) Global Priority List of Antibiotic-Resistant Bacteria (9).”
- Antibiotic resistance and persistence—Implications for human health and treatment perspectives (2020, positive): “The WHO listed all ESKAPE pathogens among the twelve bacterial species against which new chemotherapeutics are desperately needed (Tacconelli et al , 2018).”
- Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review (2019, background): “Over expressing multidrug efflux pumps, commonly found in resistant pathogens, are reported to affect the intracellular concentration of PS used in aPDT, thus limiting its action (Tegos and Hamblin, 2006).”